Intrinsic Value of S&P & Nasdaq Contact Us

Labcorp Holdings Inc. LH NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
58/100
2/7 Pass
SharesGrow Intrinsic Value
$367.74
+36.8%
Analyst Price Target
$321.33
+19.5%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Labcorp Holdings Inc. (LH) has shown declining revenue growth over the past 3 years, expanding from $14.9B to $14.0B (average -1.3%/yr). Net income reached $877M, reflecting solid earnings growth at +9.5%/yr on average. The net profit margin is 6.3%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 26.8% (low), with a -2.7pp trend over the period. With a $22B market cap and MOAT composite score of 54/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (40/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 38-year history, the company was profitable in 34 of 38 years — a solid long-term record with occasional losses
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (54/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 58/100 with 2/7 criteria passed.

58/100
SG Score
View full scorecard →
VALUE
36/100
Price-to-Earnings & upside
→ IV page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $10.46
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
54/100
Score: 54/100
GM 26.8% (-2.7pp)
Proven by this page
~
GROWTH
40/100
Rev -1.3%/yr
NI +9.5%/yr
Proven by this page
~
INCOME
45/100
Margin 6.3%
$14.0B
Proven by this page
Labcorp Holdings Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $13.95B$13.95B$13.01B$12.16B$14.88B
Gross Profit $3.94B$3.73B$3.5B$3.36B$4.39B
Gross Margin 28.2%26.8%26.9%27.7%29.5%
Operating Income $1.5B$1.52B$1.09B$725.6M$1.77B
Net Income $876.5M$876.5M$746M$418M$1.28B
Net Margin 6.3%6.3%5.7%3.4%8.6%
EPS (Diluted) $10.46$10.46$8.84$4.77$13.96
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message